ABSI Absci Corporation

NASDAQ

$9.74

Absci Corporation (ABSI) is expected to report earnings on November 12, 2026, after the market close. The consensus earnings estimate is a loss of $0.15 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +8.0% since its last earnings release on August 11, 2026.

Absci Missed Consensus Estimates

Tuesday, August 11, 2026 · 4:05 PM ET

3rd Quarter, Sep 2026

Thursday · 4:05 PM ET

Earnings Whisper

-

vs ($0.15)

Rev est $2.63M

Volatility

Enter your expectations below to reveal the current volatility.

Trend Analysis

Expectation

Earnings

Price action

Signals

Score

Sentiment

Grade

Life Cycle

Call Analysis

Earnings-AVWAP $9.26

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Absci Corporation

Absci is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins.

Sector

Healthcare

Industry

Biotechnology

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.